Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Bonnotte

Showing results (141-150 of 224) with videos related to

Pageof 23
Sort By:
European Journal of Internal Medicine|February 21, 2021
Myocardial infarction during giant cell arteritis: A cohort studyHélène Greigert, Marianne Zeller, Alain Putot, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2015
Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytesNona Janikashvili, Malika Trad, Alexandrine Gautheron, et al.
Presse Medicale (Paris, France : 1983)|July 10, 2020
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenanceBenjamin Terrier, Pierre Charles, Olivier Aumaître, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicenter cohort studyAgathe Sinnaeve, Brigitte Bader-Meunier, Anne Mirguet, et al.
European Journal of Internal Medicine|July 29, 2018
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective studyMaxime Samson, Hervé Devilliers, Kim Heang Ly, et al.
Rheumatology (Oxford, England)|January 1, 2019
Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literatureLaurent Arnaud, Pierre Edouard Gavand, Rheinardt Voll, et al.
Blood|July 21, 2023
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agentsNatasha Ollier, Marie-Léa Piel-Julian, Matthieu Mahévas, et al.
American Journal of Hematology|October 7, 2025
Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 PatientsCindy Marques, Guillaume Moulis, Mickaël Roussotte, et al.
Blood|August 31, 2011
Immunologic effects of rituximab on the human spleen in immune thrombocytopeniaSylvain Audia, Maxime Samson, Julien Guy, et al.
Journal of Autoimmunity|December 1, 2023
Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritisHélène Greigert, André Ramon, Coraline Genet, et al.
Pageof 23

Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
European Journal of Internal Medicine|February 21, 2021
Myocardial infarction during giant cell arteritis: A cohort studyHélène Greigert, Marianne Zeller, Alain Putot, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2015
Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytesNona Janikashvili, Malika Trad, Alexandrine Gautheron, et al.
Presse Medicale (Paris, France : 1983)|July 10, 2020
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenanceBenjamin Terrier, Pierre Charles, Olivier Aumaître, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicenter cohort studyAgathe Sinnaeve, Brigitte Bader-Meunier, Anne Mirguet, et al.
European Journal of Internal Medicine|July 29, 2018
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective studyMaxime Samson, Hervé Devilliers, Kim Heang Ly, et al.
Rheumatology (Oxford, England)|January 1, 2019
Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literatureLaurent Arnaud, Pierre Edouard Gavand, Rheinardt Voll, et al.
Blood|July 21, 2023
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agentsNatasha Ollier, Marie-Léa Piel-Julian, Matthieu Mahévas, et al.
American Journal of Hematology|October 7, 2025
Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 PatientsCindy Marques, Guillaume Moulis, Mickaël Roussotte, et al.
Blood|August 31, 2011
Immunologic effects of rituximab on the human spleen in immune thrombocytopeniaSylvain Audia, Maxime Samson, Julien Guy, et al.
Journal of Autoimmunity|December 1, 2023
Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritisHélène Greigert, André Ramon, Coraline Genet, et al.
Pageof 23